Undisclosed Funded Biotechnology Startups
The ten most recent undisclosed-round biotechnology companies in this dataset span from December 2021 through October 2022, with disclosed amounts ranging…
The ten most recent undisclosed-round biotechnology companies in this dataset span from December 2021 through October 2022, with disclosed amounts ranging from $520K (Ostentus Therapeutics, Newport Beach) to $180M (Retro Biosciences, San Francisco). Two companies — Humanode, based in Batum, Georgia, and Neuvivo out of Palo Alto — did not publish a dollar figure alongside their round announcements.
California accounts for three of the ten entries, with Retro Biosciences, Neuvivo, and Ostentus Therapeutics spread across San Francisco, Palo Alto, and Newport Beach. The remaining companies are distributed across Wisconsin, Minnesota, Missouri, the Netherlands, Canada, and the United Kingdom. Micreos, based in Wageningen, raised $25M — the second-largest disclosed figure in this set. Six of the ten rounds fall below $1M, with smaller raises from companies like Stratix Labs ($500K, Saint Paul) and InterShunt ($900K, St. Louis) representing the lower end of the disclosed range.
Most recent rounds
10 shownRelated listings
Frequently asked
What is the largest disclosed round among these biotechnology companies?
Retro Biosciences in San Francisco raised $180M in April 2022, the largest disclosed amount in this set by a wide margin. Micreos, based in Wageningen, Netherlands, ranks second at $25M, with no other company in these ten rows exceeding $6M.
Which companies closed rounds without disclosing a dollar amount?
Humanode (Batum, Georgia) and Neuvivo (Palo Alto, California) both announced rounds with no figure published — Humanode in September 2022 and Neuvivo in May 2022. The remaining eight companies disclosed amounts ranging from $500K to $180M.
How are these companies distributed geographically?
California leads with three entries — Retro Biosciences (San Francisco), Neuvivo (Palo Alto), and Ostentus Therapeutics (Newport Beach). Four of the ten companies are headquartered outside the United States: Micreos (Netherlands), Humanode (Georgia), Chinova Bioworks (Canada), and Atelerix (United Kingdom).
What deal sizes are most common in this segment?
Six of the ten rounds fall below $1M: Stratix Labs ($500K), Atelerix ($600K), InterShunt ($900K), Chinova Bioworks ($1M), and Ostentus Therapeutics ($520K) cluster at the lower end. Only Retro Biosciences, Micreos, and GenoPalate exceed $1M among companies with disclosed figures.
What time span do these rounds cover?
The ten rounds run from December 2021 (InterShunt, St. Louis) through October 2022 (GenoPalate in Wauwatosa and Micreos in Wageningen, both on October 25). Activity is concentrated between February and October 2022, with seven of the ten rounds closing in that window.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.